Lab-grown blood stem cells: A game-changer for cancer treatment
New Scientist - 02-Sep-2024New stem cell breakthrough offers personalized cancer treatment with less rejection risk
Join the club for FREE to access the whole archive and other member benefits.
Professor of Stem Cell Medicine at the Murdoch Children’s Research Institute, Australia
Professor Andrew Elefanty leads the Blood Diseases Laboratory at the Murdoch Children’s Research Institute (MCRI), where his research focuses on the differentiation of human pluripotent stem cells to model and understand blood diseases in vitro and for transplantation purposes. After training as a physician and completing a PhD in leukaemogenesis at the Walter and Eliza Hall Institute under Professor Suzanne Cory, he worked on globin gene regulation with Professor Frank Grosveld in London. He later returned to the Hall Institute to pursue developmental haematopoiesis and mouse embryonic stem cell differentiation. Moving to Monash University in 2002, he began studies with human embryonic stem cells before relocating his laboratory to MCRI in 2013. In collaboration with Dr. Elizabeth Ng and Professor Ed Stanley, he has made significant contributions to the generation of genetically modified human stem cell lines with lineage-specific fluorescent reporters.
Visit website: https://www.mcri.edu.au/researcher-details/andrew-elefanty
See also: Murdoch Children's Research Institute (MCRI) - Child health research institute.
Details last updated 04-Sep-2024
New stem cell breakthrough offers personalized cancer treatment with less rejection risk